Effects of Telitacicept vs Cyclophosphamide on Lupus Related Interstitial Lung Disease

Clinical trial NCT07077486 · RECRUITING

Trial details

NCT number: NCT07077486
Sponsor: Tongji Hospital
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Lupus or SLE Interstitial Lung Disease Systemic Lupus Erythematosus

Start date: 2025-08-25
Primary completion: 2026-10-25
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.